SCHEMBL14924946

SCHEMBL14924946

COc1ccc(-n2c(-c3cc(C(C)C)c(C)cc3C)n[nH]c2=S)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.55
HTT P42858 1/20 0.55
CUL4A Q13619 1/20 0.55
KDM4E B2RXH2 4/20 0.54
ALDH1A1 P00352 4/20 0.54
HSD17B10 Q99714 2/20 0.54
TSHR P16473 1/20 0.54
PKM P14618 1/20 0.53
GAA P10253 3/20 0.51
KMT2A Q03164 2/20 0.51
CYP3A4 P08684 1/20 0.50
RECQL P46063 1/20 0.50
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
CA12 O43570 1/20 0.48
CA9 Q16790 1/20 0.48
APOBEC3G Q9HC16 2/20 0.48
LMNA P02545 1/20 0.48
PRNP P04156 1/20 0.48
PPARG P37231 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14925072 0.86 HPGD (0.48) HPGDHTTCUL4AKDM4EALDH1A1
SCHEMBL14925004 0.86 HSP90AB1 (0.50)
SCHEMBL4999423 0.85 HSP90AA1 (0.61) HPGDHTTCUL4AKDM4EALDH1A1
SCHEMBL4999281 0.85 HPGD (0.54) HPGDHTTCUL4AKDM4EALDH1A1
SCHEMBL14924909 0.82 HSP90AA1 (0.47) HPGDHTTKDM4EALDH1A1HSD17B10
SCHEMBL4999280 0.80 HPGD (0.49) HPGDHTTCUL4AKDM4EALDH1A1
SCHEMBL14924990 0.79 UCHL3 (0.41) HPGDKDM4EKMT2ACYP3A4APOBEC3G
SCHEMBL13983077 0.78 KDM4E (0.61) HPGDHTTCUL4AKDM4EALDH1A1
SCHEMBL14925080 0.77 HSP90AA1 (0.41) HPGDKDM4EALDH1A1KMT2AMEN1
SCHEMBL14924917 0.77 HSP90AA1 (0.41) KMT2ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130116253-A1 Novel HSP90 Inhibitor NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-05-09 US disclosed
US-20130116252-A1 Novel HSP90 Inhibitor NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-05-09 US disclosed
US-20130116431-A1 Novel HSP90 Inhibitor NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-05-09 US disclosed
US-20130116251-A1 Novel HSP90 Inhibitor NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116252-A1 Novel HSP90 Inhibitor HSP90AB1, HSP90AB2P, HSP90B1 HPGD 1300/4885HTT 2339/4885CUL4A 1488/4885
US-20130116253-A1 Novel HSP90 Inhibitor HSP90AB1, HSP90AB2P, HSP90B1 HPGD 1300/4885HTT 2339/4885CUL4A 1488/4885
US-20130116251-A1 Novel HSP90 Inhibitor HSP90AB1, HSP90AB2P, HSP90B1 HPGD 1300/4885HTT 2339/4885CUL4A 1488/4885
US-20130116431-A1 Novel HSP90 Inhibitor HSP90AB1, HSP90AB2P, HSP90B1 HPGD 1300/4885HTT 2339/4885CUL4A 1488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.